Article Details

Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services

Retrieved on: 2024-02-15 00:02:24

Tags for this article:

Click the tags to see associated articles and topics

Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services. View article details on hiswai:

Excerpt

KNOXVILLE, TN, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced.

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo